What's new

Coronavirus: Dexamethasone proves first life-saving drug

MenInG

PakPassion Administrator
Staff member
Joined
Oct 2, 2004
Runs
217,991
A cheap and widely available drug called dexamethasone can help save the lives of patients who are seriously ill with coronavirus.

UK experts say the low-dose steroid treatment is a major breakthrough in the fight against the deadly virus.

It cut the risk of death by a third for patients on ventilators. For those on oxygen, it cut deaths by a fifth.

The drug is part of the world's biggest trial testing existing treatments to see if they also work for coronavirus.

Researchers estimate that if the drug had been used to treat patients in the UK from the start of the coronavirus pandemic up to 5,000 lives could have been saved. Because it is cheap, it could also be of huge benefit in poorer countries struggling with high numbers of Covid-19 patients.

About 19 out of 20 patients with coronavirus recover without being admitted to hospital. Of those who are admitted to hospital, most also recover, but some may need oxygen or mechanical ventilation. These are the high-risk patients whom dexamethasone appears to help.

The drug is already used to reduce inflammation in a range of other conditions, and it appears that it helps stop some of the damage that can happen when the body's immune system goes into overdrive as it tries to fight off coronavirus.

The body's over-reaction is called a cytokine storm and it can be deadly.

In the trial, led by a team from Oxford University, around 2,000 hospital patients were given dexamethasone and were compared with more than 4,000 who did not receive the drug.

For patients on ventilators, it cut the risk of death from 40% to 28%. For patients needing oxygen, it cut the risk of death from 25% to 20%.

Chief investigator Prof Peter Horby said: "This is the only drug so far that has been shown to reduce mortality - and it reduces it significantly. It's a major breakthrough."

Lead researcher Prof Martin Landray says the findings suggest that for every eight patients treated on ventilators, you could save one life.

For those patients treated with oxygen, you save one life for approximately every 20-25 treated with the drug.

"There is a clear, clear benefit. The treatment is up to 10 days of dexamethasone and it costs about £5 per patient. So essentially it costs £35 to save a life. This is a drug that is globally available."

Prof Landray said, when appropriate, hospital patients should now be given it without delay, but people should not go out and buy it to take at home.

Dexamethasone does not appear to help people with milder symptoms of coronavirus - those who don't need help with their breathing.

The Recovery Trial has been running since March. It included the malaria drug hydroxychloroquine which has subsequently been ditched amid concerns that it increases fatalities and heart problems.

Another drug called remdesivir, an antiviral treatment that appears to shorten recovery time for people with coronavirus, is already being made available on the NHS.

https://www.bbc.com/news/health-53061281
 
The above is a big news..if true! I know people have given up on this thread but that's a huge news and bbc is reporting it,sounds genuine as well.
 
<blockquote class="twitter-tweet"><p lang="en" dir="ltr">What is so important is that dexamethasone is so cheap.<br><br>We've seen poorer countries struggle to deal with the virus, but most can access this drug easily so countless lives could be saved. It can help patients on oxygen too.<br><br>Some much-needed good news for the whole world.</p>— Professor Karol Sikora (@ProfKarolSikora) <a href="https://twitter.com/ProfKarolSikora/status/1272878571992887298?ref_src=twsrc%5Etfw">June 16, 2020</a></blockquote> <script async src="https://platform.twitter.com/widgets.js" charset="utf-8"></script>

Point.
 
Before people start playing doctor doctor let the actual experts speak on the matter. This is what Dr Faheem has to say about it, he has been an authority on all things related to corona ever since the pandemic start. Besides the news report itself says it's not a magic cure and improved health of 1/3 patients that were on ventilators


<blockquote class="twitter-tweet"><p lang="en" dir="ltr">Are steroids the best option to treat COVID?<br><br>This trial of over 2000 patients found a significant mortality benefit for patients requiring ventilation or high flow oxygen. <br><br>Previous studies showed no benefit/harm. Brace for lots of discussion on this...<a href="https://t.co/EfY3NJaz7d">https://t.co/EfY3NJaz7d</a></p>— Faheem Younus, MD (@FaheemYounus) <a href="https://twitter.com/FaheemYounus/status/1272883779200339968?ref_src=twsrc%5Etfw">June 16, 2020</a></blockquote> <script async src="https://platform.twitter.com/widgets.js" charset="utf-8"></script>
 
Great news. But lets take the news for what it is, it's no silver bullet. It also seems to only help serve patients so can't use it to prevent severe infection, from what I gather.

Still being cheap, available and proven mortality reduction, this is a great first step in treating COVID-19. Tocilizumab is another drug that seems to work.

Ivermectin has evidence in it's support too, but we need a RCT to really see if it works. Hopefully soon.

Finally this is why we need to flatten the curve. Buys more time to find treatments.
 
Good news. Instead of finding a new drug, dexamethasone is a licensed, off-the-shelf treatment whose safety is already established.
 
Out of stock in Lahore and being sold on black probably!
 
Drug is 'the start' in battle against Covid-19 - Vallance

Horby says the results of the trial are "really good news" in the battle against coronavirus.

"I think this is really good news that almost every patient can take and they will get benefit from it," he says.

He adds that further trials are continuing.

Vallance points out that this is the first drug that's proven to reduce the risk of death from Covid-19.

"That's the start of something - it shows this is possible to do and as other drugs get looked at it's hoped they will add to that," he says.


==

Life-saving drug 'extremely cheap'

Horby says the drug has been around for decades and is "extremely cheap".

The professor explains that the cost of saving eight patients in intensive care was about £40.

He says a study of the drug found "remarkable" results - and it could reduce the chance of death by about 35% for patients on ventilators.

For those who require oxygen it was about 20%, he says.

But he says it is "not a drug that you would use in the community" at large.
 
Before people start playing doctor doctor let the actual experts speak on the matter. This is what Dr Faheem has to say about it, he has been an authority on all things related to corona ever since the pandemic start. Besides the news report itself says it's not a magic cure and improved health of 1/3 patients that were on ventilators


<blockquote class="twitter-tweet"><p lang="en" dir="ltr">Are steroids the best option to treat COVID?<br><br>This trial of over 2000 patients found a significant mortality benefit for patients requiring ventilation or high flow oxygen. <br><br>Previous studies showed no benefit/harm. Brace for lots of discussion on this...<a href="https://t.co/EfY3NJaz7d">https://t.co/EfY3NJaz7d</a></p>— Faheem Younus, MD (@FaheemYounus) <a href="https://twitter.com/FaheemYounus/status/1272883779200339968?ref_src=twsrc%5Etfw">June 16, 2020</a></blockquote> <script async src="https://platform.twitter.com/widgets.js" charset="utf-8"></script>

I believe the initial guidelines all recommended to avoid steroids as treatment for covid as it was associated with worse outcomes in the MERS and the 2003 SARs outbreak. I don't know if these might be the 'previous studies' the good doctor is referring to? The trial that tested dex is called the RECOVERY trial and as far as I am aware, it's a UK based national trial. It would be interesting to see what other countries have found if they had a dexamethasone arm but I don't think many trials used this because as I mentioned above, the outcomes were poor in pervious respiratory viruses.
 
WHO to update guidance after breakthrough trial

The World Health Organization (WHO) has said it will update its clinical guidelines after a trial showed that a cheap and widely available drug can help save the lives of patients seriously ill with coronavirus.

The low-dose steroid treatment dexamethasone is a major breakthrough in the fight against the deadly virus, UK experts say.

The WHO's clinical guidance is meant to keep doctors and other medical professionals informed with the latest data.

"This is the first treatment to be shown to reduce mortalityin patients with Covid-19 requiring oxygen or ventilatorsupport," WHO chief Tedros Adhanom Ghebreyesus said on Tuesday.

Results from Tuesday's trial are still preliminary, but it showed that dexamethasone cut death rates by by a third for patients on ventilators. For those on oxygen, it cut deaths by a fifth.

Had the drug had been used to treat patients in the UK from the start of the pandemic, up to 5,000 lives could have been saved, researchers said.

The BBC spoke to a patient who survived Covid-19 after taking part in the trial. She said she feels "eternally grateful" and believes she would have died without it.

Video content
 
Punjab government has started to monitor and control the sale of Dexamethasone (injection and tablet) in a bid to prevent the steroid's profiteering and hoarding after the Oxford University confirmed on Tuesday that it can be used to save the life of critically-ill coronavirus patients.

The scientists believe the drug, which is easily available and cheap, could be of huge benefit in poorer countries with high numbers of Covid-19 patients.

The doctors in Pakistan, however, are already prescribing the medicine to seriously ill coronavirus patients. “We are already prescribing the dexamethasone, both in the public and private sector, to patients with coronavirus having infiltrated into their lungs,” confirmed Prof Dr Irshad Hussain, former head of Department of Medicine at King Edward Medical University (KEMU)/ Mayo Hospital, Lahore.

However, the study reinforces the treatment after a successful trial with a definitive result of considerable reduction in mortality among critically-ill Covid-19 patients.

Prof Irshad Hussain said that the drug improved oxygen saturation of serious COVID-19 patients and also averted their admission to hospitals. “When the body's immune system overreacts to fight off coronavirus, it suppresses the cytokine storm,” he added.

However, he said, the drug does not respond to certain serious patients. “Therefore, replacement medicines such as Actemra (Tucilizumab) are being trial-run,” he added.

Noor Muhammad Mehr, an eminent pharmacist and drug lawyer, said that the successful trial of Dexamethasone on coronavirus patients could turn fortunes of serious COVID-19 patients in countries like Pakistan.

Dexamethasone, he says, is a type of corticosteroid medication, which is used to reduce inflammation in a range of other conditions such as rheumatoid arthritis and asthma, a number of skin diseases, severe allergies, chronic obstructive lung disease, croup, brain swelling, ocular pain following ophthalmic surgery, and along with antibiotics in tuberculosis.

In adrenocortical insufficiency, he says, it should be used together with a medication that has greater mineralocorticoid effects such as fludrocortisone. In preterm labour, he said, it may be used to improve outcomes in the baby’s health.

Noor Mehr said that the drug, Dexamethasone, was easily available in the market under various brand names, which is being sold between MRP 45 and 300. “It may be taken orally or as an injection into a muscle or intravenously,” he said, adding that the effects of Dexamethasone are frequently seen within a day and last for about three days.

Meanwhile, in reference to recent developments in the treatment of COVID-I9 where Dexamethasone may be effective in the treatment of the infectious disease, the chief drug controller wrote a letter to drug controller/deputy drug controller/drug inspector, Punjab, saying that monitoring and control of the sale of the said drug was of utmost importance in current circumstances, so that sufficient quantities be made available for the treatment of COVID-I9 patients.

Thus, he directed the officials to monitor the distribution of the drug. The respective drug inspector should obtain the current stock position from the distributors of the relevant brands of injection and tablet and report to the Chief Drug Controller (CDC) office. Furthermore, all the drug inspectors should ensure the sale of the drug strictly on the prescription of the registered medical practitioners.

It is further directed that the drug inspectors should also reveal the brands of Dexamethasone currently available in the market, along with their distribution setups and submit their reports to the CDC office by Wednesday (today) till 12 PM.

The Punjab government is in the process of a trial-run of Actemra (Tucilizumab) on critically-ill coronavirus patients to see its efficacy and further recommendation accordingly.

https://www.geo.tv/latest/293522-pu...e-distribution-of-covid-19-drug-dexamethasone
 
Standing up in the Commons after questions to the UK Prime Minister, Health Secretary Matt Hancock has been updating MPs on the steroid dexamethasone, which has been found to be an effective treatment for patients seriously ill with coronavirus.

He says there are 240,000 doses in stock and on order. And that means it's already being used in the NHS.

“It is not by any means a cure,” he says, “but it is the best news we've had.”

This development is what “good science looks like”, he says, in terms of controlled research, and it means there is “objective proof this drug saves lives”, which will benefit thousands of people across the world.

He says seven other drugs are being tested in the "recovery" trial and another nine as part of the ACCORD programme, which is looking at early stage treatments.

Hancock thanks everyone involved, including deputy chief medical officer Jonathan Van Tam, NHS clinicians, scientific teams and the people who took part in the trial before they even knew it worked.
 
Dexamethasone being used to treat NHS patients today

A life-saving treatment for seriously-ill hospital patients with Covid-19 is being used across the UK from today, following breakthrough results in a UK trial.

Dexamethasone - a cheap, widely-available steroid - was shown to reduce deaths among patients on ventilators and on oxygen.

The UK's chief medical officers say it should be used "with immediate effect".

And there are no issues with supplies of the medicine in the UK.

In an urgent letter from the UK's four chief medical officers to clinicians in the NHS, they said dexamethasone had "a clear place in the management of hospitalised patients with Covid-19".

'Major breakthrough'
The anti-inflammatory drug was tested as part of the world's biggest trial of existing treatments to see if they could also work against coronavirus.

In the trial, led by a team from Oxford University, about 2,000 hospital patients were given dexamethasone and compared with more than 4,000 who were not.

For patients on ventilators, it cut the risk of death from 40% to 28%. For patients needing oxygen, it cut the risk of death from 25% to 20%.

The researchers said this was equivalent to one life being saved for every eight patients on a ventilator and one life being saved for every 20-25 being treated with oxygen.

On Monday 15 June, 385 people with Covid-19 were on mechanical ventilation in hospitals in the UK with hundreds more likely to be on oxygen support.

They could all be candidates for receiving dexamethasone.

The drug works by dampening down the reaction of the body's immune system to on Covid-19, which can often be more harmful than the virus itself.

Chief investigator Prof Peter Horby said it was "the only drug so far that has been shown to reduce mortality - and it reduces it significantly".

"It's a major breakthrough," he added.

However, it should not be used to treat anyone with coronavirus who is not in hospital. Its use is still being studied in children.

Already used to reduce inflammation in a range of other conditions, including arthritis, asthma and some skin conditions, the cost of the drug would be as little as £5 per patient.

The government said it had already bought additional stocks of dexamethasone and now had enough treatment for more than 200,000 people.

The drug is also widely available around the world.
https://www.bbc.com/news/health-53077893
 
Dexamethasone should only be used to treat critically ill Covid-19 patients: Dr Mirza

Special Assistant to the Prime Minister on Health Dr Zafar Mirza has said that steroid dexamethasone should only be used to treat critically ill Covid-19 patients.

Speaking to anchorperson Shahzeb Khanzada on Geo News, he advised against employing the drug to treat asymptomatic or mild patients of the novel coronavirus.

"This drug has side effects. It should only be used by doctors to treat hospitalised, critically ill, dying patients," he said.

He said that he had heard that the drug was already becoming scarce in Pakistani markets.

"It's unfortunate because this [drug's scarcity] means that people are either hoarding it or have started using it without doctors' recommendation," he said.
 
The US has suffered 722 more deaths and registered 27,975 new cases, according to the Centers for Disease Control and Prevention (CDC). That takes the official totals to 116,862 and 2,132,321, respectively.

==

Reserve new treatment for most serious cases – WHO

The cheap steroid British researchers believe can help save lives should be used only for the most serious cases, the World Health Organization (WHO) has said.

The WHO chief Dr Tedros Adhanom Ghebreyesus said research was at last providing “green shoots of hope”.

Trial results announced on Tuesday showed dexamethasone, a generic drug used since the 1960s to reduce inflammation in diseases such as arthritis, cut death rates by around a third among the most severely ill patients admitted to hospital.

The head of the WHO’s emergencies programme, Dr Mike Ryan, said the drug should only be used in the cases where it has been shown to help.

It is exceptionally important in this case, that the drug is reserved for use in severely ill and critical patients who can benefit from this drug clearly.
 
ISLAMABAD: The Islamabad Capital Territory Administration (ICTA) has decided to launch an action against the drug stores involved in hoarding dexamethasone drug, which is being prescribed to coronavirus patients.

However, the profiteers taking advantage of the situation hoarded huge quantities of otherwise widely available cheap medicine.

In this regard, Islamabad Deputy Commissioner (DC) Hamza Shafqat issued a notification on Wednesday.

It read that the district administration will form special teams to carry out action against the pharmacies and drug stores involved in the practice.

DC has directed all pharmacies to ensure the uninterrupted supply of the drug and sell it only to those having a doctor’s prescription.

The drug stores have been instructed to maintain records of sales and purchase of the medicine.

Assistant Commissioners (ACs) have been directed to check the record of pharmacies for transparency.

On selling of dexamethasone in hiked prices or hoarding it for profiteering, the pharmacists will face action under Hoarding Act 1977, Drug Act 1976 and Drug Regulatory Authority Pakistan (DRAP) 2012 Act Schedule-II.
 
LAHORE: Dexamethasone, a steroid drug that has shown to be effective in the treatment of critical Covid-19 patients, has reportedly disappeared from markets in Lahore.

The otherwise widely available cheap Dexamethasone tablets are being sold for Rs1,000 to Rs1,500 per packet in the black market as the profiteers have hoarded huge quantities of medicine.

Health experts, however, have warned against the use of the drug without a registered medical practitioner’s advice saying it could prove potentially hazardous to one’s health.

Earlier, on June 18, the Ministry of National Health Services had announced that the drug will only be sold to customers having a valid prescription issued by a registered medical practitioner.

“All pharmacies shall ensure uninterrupted supplies and availability of the drug at the price fixed by the Drug Regulatory Authority of Pakistan. The drug shall be sold only to customers with valid prescription,” read a notification issued by the ministry.

“Pharmacies and distributors are hereby directed to maintain the sale and purchase of the drug and submit the record, along with hard copies of prescriptions to the Inspector of Drugs on a fortnightly basis.”

https://arynews.tv/en/dexamethasone-drug-disappears-from-markets-in-lahore/
 
Ten million dexamethasone tablets could be ready in a month: Aspen

South African pharmaceutical company Apen has said it could provide 10 million dexamethasone tablets within a month.

The commments were made by CEO Stephen Saad who said Aspen "would look to ramp up further should there be a need for additional product".

In what was described as a major breakthrough in the fight against the coronavirus, trial results last week that dexamethasone reduced death rates by about a third compared with a placebo in severely ill hospitalised COVID-19 patients.

The South African government has contacted Aspen to source the cheap and widely available steroid not only for its domestic market but also for the rest of the continent.

"Once they give us a sense [required volumes across the continent], we can work out the supply," Saad said.
 
Back
Top